Research And Trials
Combining information from different cancer scans could offer a way to predict if immunotherapy will work, according to a small unpublished study.
We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.
Different types of brain tumours may share similar survival strategies, opening up new treatment research avenues.
The most aggressive type of ovarian cancer develops from cells that come from the fallopian tubes rather than the ovaries, according to a small study.
Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.
A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia
A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers.
The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.